Pharmaceutical Policy Analysis

About

Medicines are among the most regulated products in society. From the earliest pre-clinical stages onward, policy makers want to foster the development of safe, effective and affordable medicines for patients in need of treatment. When a drug reaches the market, it is the beginning of a process of complex interactions between patients, prescribers, insurers, pharmaceutical companies and governments. Furthermore, the inequity in access to medicines is still a defining characteristic of the global pharmaceutical market place. The aim of the course is to give students insight into current developments in pharmaceutical policy making as well as to give them a better understanding of the methods available for analysing the effects of policy interventions.

You will experience an intensive programme covering the following topics: pharmaceutical policy analysis issues and methods; availability and affordability of medicines; universal health coverage; pricing and reimbursement (including the role of health technology assessment); regulatory issues and challenges; policy and politics; synthesis, case studies & public health.

Course leader

Prof. dr. Aukje Mantel-Teeuwisse & Dr. Rianne van den Ham

Target group

(Post)graduates and professionals within governments, NGOs, industry, universities with a basic knowledge of public health/medicine, who have an interest in the policy aspects of pharmaceuticals and/or pharmacoepidemiology.

Course aim

The aim of the course is to give students insight into current developments in pharmaceutical policy making as well as to give a better understanding of the methods available for analysing the effects of policy interventions.

Fee info